Efficacy of the combination of tobramycin and a macrolide in an in vitro Pseudomonas aeruginosa mature biofilm model.
about
The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic managementDynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment.Azithromycin may antagonize inhaled tobramycin when targeting Pseudomonas aeruginosa in cystic fibrosisPseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatmentCombined treatment of Pseudomonas aeruginosa biofilms with bacteriophages and chlorine.Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilmEnhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products.Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis.Effects of azithromycin in Pseudomonas aeruginosa burn wound infection.Aerosolized antibiotics in cystic fibrosis: an update.Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis.Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives.Antibiofilm Peptides: Potential as Broad-Spectrum AgentsEffect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilmsIn vitro synergy of antibiotic combinations against planktonic and biofilm Pseudomonas aeruginosa.
P2860
Q28730299-AD2948D0-7376-4019-B47C-1BE69AE36654Q31029779-DBBD1330-5260-47CB-8729-F46EDD8D78DBQ33640512-F63D66E0-8EB6-42C5-92C6-4BEED44F0BD7Q33824149-2D20DEF1-52C1-4101-BCFB-407B07B326A4Q34377473-896C1168-EE72-47EF-90B4-8D1ACDAAF344Q34408724-CF1C1491-1762-4115-AECD-77F9199B662CQ34596738-D487AF4E-FABC-43A7-8C99-EFA271CC6411Q35426622-3F9BE05A-8E4E-4965-95C6-65C30DEE006FQ37018035-135804DE-9F1A-4337-AFD9-361C88941287Q38212537-EF9B2DE6-38C3-4362-8696-72E202A32912Q38447194-BBAC0005-DBEA-4A9E-A61E-35DF88094D48Q38569772-1DABD875-82E3-405F-ACBF-FCAC39402A7AQ38805599-6DF5677A-68FE-47BD-8CC8-8CE3721F6601Q41715004-A1F0B9BB-2FCB-46DD-A0F1-9086994FF2D8Q47109183-B3CB17A9-0FEA-46A9-B28A-B5FF7ECAEEBB
P2860
Efficacy of the combination of tobramycin and a macrolide in an in vitro Pseudomonas aeruginosa mature biofilm model.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Efficacy of the combination of ...... ruginosa mature biofilm model.
@en
Efficacy of the combination of ...... ruginosa mature biofilm model.
@nl
type
label
Efficacy of the combination of ...... ruginosa mature biofilm model.
@en
Efficacy of the combination of ...... ruginosa mature biofilm model.
@nl
prefLabel
Efficacy of the combination of ...... ruginosa mature biofilm model.
@en
Efficacy of the combination of ...... ruginosa mature biofilm model.
@nl
P2093
P2860
P356
P1476
Efficacy of the combination of ...... ruginosa mature biofilm model.
@en
P2093
Carole Nagant
Francis Vanderbist
Hamidou Traore
Jean-Paul Dehaye
Marie Tré-Hardy
Naïma El Manssouri
P2860
P304
P356
10.1128/AAC.00372-10
P407
P577
2010-08-09T00:00:00Z